Valitacell
Business Services · Ireland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Nibrt Ave, Dublin, Dublin City, IrelandPhone Number
+353 12158130Website
www.valitacell.comRevenue
$5.9 MillionIndustry
About Valitacell
Is Valitacell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Valitacell recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Valitacell has new funding data
Check if Valitacell has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Valitacell
Product Launch: Get notified when Valitacell launches new products
Click to see if Valitacell had a recent Job posting/layoffs
Valitacell, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Valitacell is spiking on competitors!
Recommended Actions
Find VP level buyers at Valitacell
Find more new buyers
Company Profile Activity
Activity Insights
Valitacell is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Valitacell is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Valitacell.
Valitacell Tech Stack
A closer look at the technologies used by Valitacell
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Valitacell
Valitacell is an Irish based biotechnology company accelerating the development of life-saving medicines with a suite of novel, intelligent analytical technology platforms, engineered to provide process control in cell-based manufacturing to achieve the highest levels of bioprocess performance. This is Valitacell's second success in the H2020 progr... Read More